Meanwhile, in an email statement, Hyland’s, a maker of homeopathic teething tablets and gel, said, “Hyland’s has not been made aware of any data that supports the claims in the warning against our teething tablets and gels. Our understanding is that the Food and Drug Administration’s investigation of these products is still ongoing. The fact is that we have not been made aware of any medical or statistical evidence to support a causal link between homeopathic teething tablets and adverse outcomes at this point. We continue to request any available information and statistics from the FDA,” reports CNN.
“This decision was made in light of the recent warning issued by the Food & Drug Administration against the use of homeopathic teething tablets and gels. This warning has created confusion among parents and limited access to the medicines,” Hyland’s employees said in a separate statement posted on its website, on Tuesday, Oct. 12. “Putting you in a position of having to choose who to trust in the face of contradictory information is burdensome and undermines the FDA.”
In the meantime, the FDA revealed they’re analyzing the adverse events connected to homeopathic teething tablets and gels, including testing product samples, as neither has been evaluated or approved by the FDA for safety or efficacy. Furthermore, the agency is encouraging health care professionals and consumers to report undesirable reactions or quality problems associated with the use of said products to the FDA’s MedWatch Adverse Event Reporting program:
Complete and submit the report online at www.fda.gov/medwatch/report.htm; or download and complete the form, then submit it via fax at 1-800-FDA-0178.